Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for pain reduction after pediatric tonsillectomy
IRCT20220508054785N1Phase 2Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Sabzevar University of Medical Sciences. Primary endpoints: Intensity of pain after tonsil surgery, Arterial blood oxygen saturation percentage during tonsillectomy and 3 more. Started Oct 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20220508054785N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220508054785N1.